VISN 5 MIRECC - General Publications 2007 - MIRECC / CoE
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

VISN 5 MIRECC - General Publications 2007

 

About Us • Clinical • Education • Research
VISN 5 MIRECC home

 

Batten, S. V., & Santanello, A. P. (2007). Review of Mindfulness and Acceptance: Expanding the Cognitive-Behavioral Tradition. Clinical Psychology Review, 27, 406-407.

Bellack, A. S., Bennett, M. E., & Gearon, J. S. (2007). Behavioral Treatment for Substance Abuse in People with Serious and Persistent Mental Illness: A Handbook for Mental Health Professionals. New York: Taylor and Francis.

Bellack, A. S., Green, M. F., Cook, J. A., et al., (2007). Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin, 33, 805-822.

Bennett, M.E. & Gjonbalaj, S. (2007). The Problem of Dual Diagnosis. In M. Hersen, S. Turner, & D. Beidel (Eds), Adult Psychopathology and Diagnosis (Fifth Ed). New York: John Wiley and Sons.

Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2007). Galantamine for the treatment of cognitive impairments in patients with schizophrenia. American Journal of Psychiatry. November 6. [Epub ahead of print]

Carpenter, W. T. (2007). Cognitive impairment and negative symptoms in schizophrenia treatment. In G. Thaker & W. T. Carpenter (Eds.), The Year in Schizophrenia (Vol 1, pp. 233-267). Oxford: Clinical Publishing.

Carpenter, W. T. (2007). Deconstructing and reconstructing illness syndromes associated with psychosis. World Psychiatry, 6(2), 28-29.

Carpenter, W. T. (2007). Schizophrenia: disease, syndrome or dimensions? Family Process, 46, 199-206.

Carpenter, W. T. & Thaker, G. K. (2007). Evidence-based therapeutics – introducing the Cochrane Corner. Schizophrenia Bulletin, 33(3), 633-634.

Daumit, G., Durant, N., Dixon, L. (2007). Co-occurring substance use and somatic disorders. In G. Thaker & W. Carpenter (Eds.), The Year in Schizophrenia. Ashland: Clinical Publishing.

Deutsch, S. I., Mastropaolo, J., Schwartz, B. L., Rosse, R. B., & Gaskins, B. (2007). NMDA receptor hypofunction in schizophrenia: from mouse to man. In G. McAlpine (Ed.), Focus on Signal Transduction Research (pp. 103-122). New York: Nova Science Publishers, Inc.

Deutsch, S. I., Rosse, R. B., Schwartz, B. L., Schooler, N. R., Gaskins, B. L., Long, K. D., & Mastropaolo, J. (2007). Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: Development of a selective α7 nicotinic acetylcholine receptor agonist strategy. European Neuropsychopharmacology. July 24. [Epub ahead of print]

Dickinson, D., Bellack, A. S., & Gold, J. M. (2007). Social/communication skills, cognition, and vocational functioning in schizophrenia. Schizophrenia Bulletin, 33(5), 1213-20.

Dickinson, D., & Gold, J. M. (2007). Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophrenia Bulletin. Aug 16. [Epub ahead of print]

Dickinson, D., & Gold, J. M. (2007). Processing speed and the digit symbol substitution test in schizophrenia. In J. Deluca & J. Kalmar (Eds.), Information Processing Speed in Clinical Populations. New York: Taylor & Francis Group.

Dickinson, D., Ramsey, M., & Gold, J. M. (2007). Overlooking the obvious: A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64, 532-542.

DiClemente, C. C., Nidecker, M., & Bellack, A. S. (2007). Motivation and the stages of change among individuals with co-occurring disorders. Journal of Substance Abuse Treatment. June 14. [Epub ahead of print].

Dixon, L., Adler, D., Berlant, J., Dulit, R., Goldman, B., Hackman, A., Oslin, D., Siris, S., Sonis, W., & Valenstein, M. (2007). Psychiatrists and primary caring: what are our boundaries of responsibility? Psychiatric Services, 58(5), 600-602.

Dixon, L., Medoff, D., Wohlheiter, K., DiClemente, C., Goldberg, R., Kreyenbuhl, J., Adams, C., Mfalila, C., Lucksted, A., & Davin, C. (2007). Correlates of severity of smoking among persons with SMI. American Journal on Addictions, 16 (2), 101-110.

Drapalski, A. L., Murray-Swank, A., Lucksted, A., Goldberg, R., Boyd Ritscher, J., Forbes, C., & Dixon, L.B. (2007). Internalized stigma and discrimination among consumers with SMI (abstract). Schizophrenia Bulletin, 33(2), 587.

Genderson, M. R., Dickinson, D., Diaz-Asper, C. M., Egan, M. F., Weinberger, D. R., & Goldberg, T. E. (2007). Factor analysis of neurocognitive tests in a large sample of schizophrenia probands, their siblings, and healthy controls. Schizophrenia Research, 94, 231-239.

Goldberg, R., Dickerson, F., Kreyenbuhl, J., Medoff, D., Wohlheiter, K., Fang, L., & Dixon, L. (2007). Quality of Diabetes Care for Persons with Severe Mental Illness. Psychiatric Services, 58, 536-543.

Goldberg, R., & Gmyrek, A. (2007). Use of medical emergency departments by veterans with schizophrenia. Psychiatric Services, 58(4), 566-567.

Goldberg, R., Kreyenbuhl, J., Medoff, D., Dickerson, F., Wohlheiter, K., Fang, L., & Dixon, L. (2007). Quality of diabetes care among adults with serious mental illness. Psychiatric Services, 58(4), 536-543.

Hackman, A., Brown, C., Yang, Y., Goldberg, R., Kreyenbuhl, J., Lucksted, A., Wohlheiter, K., & Dixon, L. (2007). Consumer satisfaction with inpatient psychiatric treatment among persons with severe mental illness. Community Mental Health Journal, 43(6), 551-564.

Hackman, A., & Dixon, L. (2007). Assertive community treatment. In P. M. Gillig & H. L. McQuistion (Eds.), Clinical Guide to the Treatment of the Homeless Mentally Ill Person (pp 51-64). Arlington, VA: American Psychiatric Publishing, Inc.

Harvey, P. D., Velligan, D. I., & Bellack, A. S. (2007). Performance-based measures of functional skills: Usefulness in clinical treatment studies. Schizophrenia Bulletin, 33(5), 1138-1148.

Himelhoch, S., McCarthy, J., Ganoczy, D., Medoff, D., Dixon, L., & Blow, F. (2007). Understanding Associations between Serious Mental Illness and HIV among Veterans: A National Multivariate Analysis. Psychiatric Services, 58, 1165-1172.

Himelhoch, S., Medoff, D., & Oyeniyi, G. (2007). Efficacy of group psychotherapy to reduce depressive symptoms among HIV infected individuals: a systematic review and meta-analysis. AIDS Patient Care and STDs, 21(10), 732-739.

Himelhoch, S., Powe, N., Breaky, W., et al. (2007). Schizophrenia, AIDS and the decision to prescribe HAART: results of a national survey of HIV clinicians. In M. B. Blank & M. M. Eisenberg (Eds.), HIV Issues with Mental Health and Illness. New York: Haworth Press.

Hong, L. E., Summerfelt, A., Adami, H. M., Wonodi, I., Buchanan, R. W., & Thaker, G. K. (2007). Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval. American Journal of Psychiatry, 164, 61-65.

Kelly, D. L., Kreyenbuhl, J., Buchanan, R. W., & Malhotra, A. K. (2007). Why Not Clozapine? Clinical Schizophrenia & Related Psychoses, 1(1), 92-95.

Kelly D. L., Kreyenbuhl, J., Dixon, L., Love, R. C., Medoff, D., & Conley, R. R. (2007). Clozapine underutilization and discontinuation in African-Americans due to leucopenia. Schizophrenia Bulletin, 33(5), 1221-1224.

Kinnaman, J. S., Bellack, A. S., Brown, C. H., & Yang, Y. (2007). Assessment of motivation to change in dually-diagnosed schizophrenia patients. Addictive Behaviors, 32(9), 1798-1813.

Kinnaman, J. S., Slade, E., Bennett, M. E., & Bellack, A. S. (2007). Examination of contingency payments to dually-diagnosed patients in a multi-faceted behavioral treatment. Addictive Behaviors, 32, 1480-1485.

Kreyenbuhl ,J., Marcus, S. C., West, J. C., Wilk, J., & Olfson, M. (2007). Adding or switching antipsychotic medications in treatment-refractory schizophrenia. Psychiatric Services, 58(7), 983-990.

Kreyenbuhl, J., Valenstein, M., McCarthy, J. F., Ganoczy, D., & Blow, F. C. (2007). Antipsychotic polypharmacy in the VA Health System: Patient characteristics and treatment patterns. Psychiatric Services, 58(4), 489-495.

Long, K. D., Mastropaolo, J., Rosse, R. B., & Deutsch, S. I. (2007). Exogenously administered D-serine failed to potentiate the ability of MK-801 to antagonize electrically precipitated seizures in nonhandled control and stressed mice. European Neuropsychopharmacology, 17(1), 53-57.

Murray-Swank, A. B., Dixon, L. B., & Stewart, B. (2007). Practical Interview Strategies for Building an Alliance with the Families of Patients with Severe Mental Illness. Psychiatric Clinics of North America, 30, 167-180.

Murray-Swank, A., Glynn, S., Cohen, A. N., Sherman, M., Medoff, D. P., Fang, L. J., et al. (2007). Family contact, experience of family relationships, and views about family involvement in treatment among VA consumers with serious mental illness. Journal of rehabilitation research and development, 44(6), 801-812.

Murray-Swank, A. B., Goldberg, R. W., Dickerson, F. B., Medoff, D. P., Wohlheiter, K. A., & Dixon, L. B. (2007). Correlates of religious service attendance and contact with religious leaders among persons with co-occurring Serious Mental Illness and Type 2 Diabetes. Journal of Nervous and Mental Disease,195(5), 382-388.

Peer, J., Kupper, Z., Long, J. D., Brekke, J. S., & Spaulding, W. (2007). Identifying mechanisms of treatment effects and recovery in rehabilitation of schizophrenia: Longitudinal analytic methods. Clinical Psychology Review, 27, 296-714.

Peer, J., & Spaulding, W. (2007). Heterogeneity in recovery of psychosocial functioning during psychiatric rehabilitation: An exploratory study using latent growth mixture modeling. Schizophrenia Research, 93, 186-193.

Prentice, K. J., Appelbaum, P. S., Conley, R. R., & Carpenter, W. T., Jr. (2007). Maintaining informed consent validity during lengthy research protocols. IRB: Ethics and Human Research, 29(6), 1-6.

Prentice, K. J., Gold, J. M. & Buchanan, R. W. (2007). The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophrenia Research. Oct 12 [Epub ahead of print].

Prentice, K. J., Robinson, B. M. & Gold, J. M. (2007). Error processing in schizophrenia: the role of WM load. Abstracts of the 11th International Congress on Schizophrenia Research. Schizophrenia Bulletin, 33, 203-631.

Schooler, N. R. (2007). Efficacy and safety of conventional and atypical antipsychotics in first-episode schizophrenia: a review of the literature. Clinical Schizophrenia & Related Psychoses, 1, 27-38.

Tenhula, W. N., Strong Kinnaman, J. E., & Bellack, A. S. (2007). Is learning potential associated with social skills in schizophrenia? Journal of Rehabilitation Research and Developm ent, 44(6), 827-836.

Thaker, G. K. (2007). Endophenotypic studies in schizophrenia: promise and challenges. Schizophrenia Bulletin, 33, 1-2.

Thaker, G. K., & Carpenter, W. T. (Eds.). (2007). The Year in Schizophrenia, Volume 1. Oxford: Clinical Publishing.

Woody, I., Reeves, R., Carmichael, D., Verovsky, I., Avila, M. T., Elliott, A., Hong, L. E., Adami, H. M., & Thaker, G. K. (2007). Tardive dyskinesia in children treated with atypical antipsychotic medications. Movement Disorders, 22(12), 1777-1782.

 

NOTE: Names in bold are VISN 5 MIRECC Investigators